purchase customization

1 Study Coverage
1.1 Oncology Based Molecular Diagnostics Product Introduction
1.2 Market by Type
1.2.1 Global Oncology Based Molecular Diagnostics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 PCR
1.2.3 Multiplex PCR
1.2.4 In Situ Hybridization
1.2.5 Isothermal Nucleic Acid Amplification Technology (INAAT)
1.3 Market by Application
1.3.1 Global Oncology Based Molecular Diagnostics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Breast Cancer
1.3.3 Prostate Cancer
1.3.4 Colorectal Cancer
1.3.5 Cervical Cancer
1.3.6 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Oncology Based Molecular Diagnostics Sales Estimates and Forecasts 2017-2028
2.2 Global Oncology Based Molecular Diagnostics Revenue Estimates and Forecasts 2017-2028
2.3 Global Oncology Based Molecular Diagnostics Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Oncology Based Molecular Diagnostics Sales by Region
2.4.1 Global Oncology Based Molecular Diagnostics Sales by Region (2017-2022)
2.4.2 Global Sales Oncology Based Molecular Diagnostics by Region (2023-2028)
2.5 Global Oncology Based Molecular Diagnostics Revenue by Region
2.5.1 Global Oncology Based Molecular Diagnostics Revenue by Region (2017-2022)
2.5.2 Global Oncology Based Molecular Diagnostics Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Oncology Based Molecular Diagnostics Sales by Manufacturers
3.1.1 Global Top Oncology Based Molecular Diagnostics Manufacturers by Sales (2017-2022)
3.1.2 Global Oncology Based Molecular Diagnostics Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Oncology Based Molecular Diagnostics in 2021
3.2 Global Oncology Based Molecular Diagnostics Revenue by Manufacturers
3.2.1 Global Oncology Based Molecular Diagnostics Revenue by Manufacturers (2017-2022)
3.2.2 Global Oncology Based Molecular Diagnostics Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Oncology Based Molecular Diagnostics Revenue in 2021
3.3 Global Oncology Based Molecular Diagnostics Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Oncology Based Molecular Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Oncology Based Molecular Diagnostics Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Oncology Based Molecular Diagnostics Sales by Type
4.1.1 Global Oncology Based Molecular Diagnostics Historical Sales by Type (2017-2022)
4.1.2 Global Oncology Based Molecular Diagnostics Forecasted Sales by Type (2023-2028)
4.1.3 Global Oncology Based Molecular Diagnostics Sales Market Share by Type (2017-2028)
4.2 Global Oncology Based Molecular Diagnostics Revenue by Type
4.2.1 Global Oncology Based Molecular Diagnostics Historical Revenue by Type (2017-2022)
4.2.2 Global Oncology Based Molecular Diagnostics Forecasted Revenue by Type (2023-2028)
4.2.3 Global Oncology Based Molecular Diagnostics Revenue Market Share by Type (2017-2028)
4.3 Global Oncology Based Molecular Diagnostics Price by Type
4.3.1 Global Oncology Based Molecular Diagnostics Price by Type (2017-2022)
4.3.2 Global Oncology Based Molecular Diagnostics Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Oncology Based Molecular Diagnostics Sales by Application
5.1.1 Global Oncology Based Molecular Diagnostics Historical Sales by Application (2017-2022)
5.1.2 Global Oncology Based Molecular Diagnostics Forecasted Sales by Application (2023-2028)
5.1.3 Global Oncology Based Molecular Diagnostics Sales Market Share by Application (2017-2028)
5.2 Global Oncology Based Molecular Diagnostics Revenue by Application
5.2.1 Global Oncology Based Molecular Diagnostics Historical Revenue by Application (2017-2022)
5.2.2 Global Oncology Based Molecular Diagnostics Forecasted Revenue by Application (2023-2028)
5.2.3 Global Oncology Based Molecular Diagnostics Revenue Market Share by Application (2017-2028)
5.3 Global Oncology Based Molecular Diagnostics Price by Application
5.3.1 Global Oncology Based Molecular Diagnostics Price by Application (2017-2022)
5.3.2 Global Oncology Based Molecular Diagnostics Price Forecast by Application (2023-2028)
6 North America
6.1 North America Oncology Based Molecular Diagnostics Market Size by Type
6.1.1 North America Oncology Based Molecular Diagnostics Sales by Type (2017-2028)
6.1.2 North America Oncology Based Molecular Diagnostics Revenue by Type (2017-2028)
6.2 North America Oncology Based Molecular Diagnostics Market Size by Application
6.2.1 North America Oncology Based Molecular Diagnostics Sales by Application (2017-2028)
6.2.2 North America Oncology Based Molecular Diagnostics Revenue by Application (2017-2028)
6.3 North America Oncology Based Molecular Diagnostics Market Size by Country
6.3.1 North America Oncology Based Molecular Diagnostics Sales by Country (2017-2028)
6.3.2 North America Oncology Based Molecular Diagnostics Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Oncology Based Molecular Diagnostics Market Size by Type
7.1.1 Europe Oncology Based Molecular Diagnostics Sales by Type (2017-2028)
7.1.2 Europe Oncology Based Molecular Diagnostics Revenue by Type (2017-2028)
7.2 Europe Oncology Based Molecular Diagnostics Market Size by Application
7.2.1 Europe Oncology Based Molecular Diagnostics Sales by Application (2017-2028)
7.2.2 Europe Oncology Based Molecular Diagnostics Revenue by Application (2017-2028)
7.3 Europe Oncology Based Molecular Diagnostics Market Size by Country
7.3.1 Europe Oncology Based Molecular Diagnostics Sales by Country (2017-2028)
7.3.2 Europe Oncology Based Molecular Diagnostics Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Oncology Based Molecular Diagnostics Market Size by Type
8.1.1 Asia Pacific Oncology Based Molecular Diagnostics Sales by Type (2017-2028)
8.1.2 Asia Pacific Oncology Based Molecular Diagnostics Revenue by Type (2017-2028)
8.2 Asia Pacific Oncology Based Molecular Diagnostics Market Size by Application
8.2.1 Asia Pacific Oncology Based Molecular Diagnostics Sales by Application (2017-2028)
8.2.2 Asia Pacific Oncology Based Molecular Diagnostics Revenue by Application (2017-2028)
8.3 Asia Pacific Oncology Based Molecular Diagnostics Market Size by Region
8.3.1 Asia Pacific Oncology Based Molecular Diagnostics Sales by Region (2017-2028)
8.3.2 Asia Pacific Oncology Based Molecular Diagnostics Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Oncology Based Molecular Diagnostics Market Size by Type
9.1.1 Latin America Oncology Based Molecular Diagnostics Sales by Type (2017-2028)
9.1.2 Latin America Oncology Based Molecular Diagnostics Revenue by Type (2017-2028)
9.2 Latin America Oncology Based Molecular Diagnostics Market Size by Application
9.2.1 Latin America Oncology Based Molecular Diagnostics Sales by Application (2017-2028)
9.2.2 Latin America Oncology Based Molecular Diagnostics Revenue by Application (2017-2028)
9.3 Latin America Oncology Based Molecular Diagnostics Market Size by Country
9.3.1 Latin America Oncology Based Molecular Diagnostics Sales by Country (2017-2028)
9.3.2 Latin America Oncology Based Molecular Diagnostics Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Oncology Based Molecular Diagnostics Market Size by Type
10.1.1 Middle East and Africa Oncology Based Molecular Diagnostics Sales by Type (2017-2028)
10.1.2 Middle East and Africa Oncology Based Molecular Diagnostics Revenue by Type (2017-2028)
10.2 Middle East and Africa Oncology Based Molecular Diagnostics Market Size by Application
10.2.1 Middle East and Africa Oncology Based Molecular Diagnostics Sales by Application (2017-2028)
10.2.2 Middle East and Africa Oncology Based Molecular Diagnostics Revenue by Application (2017-2028)
10.3 Middle East and Africa Oncology Based Molecular Diagnostics Market Size by Country
10.3.1 Middle East and Africa Oncology Based Molecular Diagnostics Sales by Country (2017-2028)
10.3.2 Middle East and Africa Oncology Based Molecular Diagnostics Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Corporation Information
11.1.2 Abbott Laboratories Overview
11.1.3 Abbott Laboratories Oncology Based Molecular Diagnostics Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Abbott Laboratories Oncology Based Molecular Diagnostics Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Abbott Laboratories Recent Developments
11.2 Bayer Healthcare
11.2.1 Bayer Healthcare Corporation Information
11.2.2 Bayer Healthcare Overview
11.2.3 Bayer Healthcare Oncology Based Molecular Diagnostics Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Bayer Healthcare Oncology Based Molecular Diagnostics Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Bayer Healthcare Recent Developments
11.3 Becton Dickinson
11.3.1 Becton Dickinson Corporation Information
11.3.2 Becton Dickinson Overview
11.3.3 Becton Dickinson Oncology Based Molecular Diagnostics Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Becton Dickinson Oncology Based Molecular Diagnostics Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Becton Dickinson Recent Developments
11.4 Cepheid
11.4.1 Cepheid Corporation Information
11.4.2 Cepheid Overview
11.4.3 Cepheid Oncology Based Molecular Diagnostics Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Cepheid Oncology Based Molecular Diagnostics Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Cepheid Recent Developments
11.5 Dako
11.5.1 Dako Corporation Information
11.5.2 Dako Overview
11.5.3 Dako Oncology Based Molecular Diagnostics Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Dako Oncology Based Molecular Diagnostics Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Dako Recent Developments
11.6 Danaher Corporation
11.6.1 Danaher Corporation Corporation Information
11.6.2 Danaher Corporation Overview
11.6.3 Danaher Corporation Oncology Based Molecular Diagnostics Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Danaher Corporation Oncology Based Molecular Diagnostics Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Danaher Corporation Recent Developments
11.7 Gen Probe(Hologic)
11.7.1 Gen Probe(Hologic) Corporation Information
11.7.2 Gen Probe(Hologic) Overview
11.7.3 Gen Probe(Hologic) Oncology Based Molecular Diagnostics Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Gen Probe(Hologic) Oncology Based Molecular Diagnostics Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Gen Probe(Hologic) Recent Developments
11.8 Roche Diagnostics
11.8.1 Roche Diagnostics Corporation Information
11.8.2 Roche Diagnostics Overview
11.8.3 Roche Diagnostics Oncology Based Molecular Diagnostics Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Roche Diagnostics Oncology Based Molecular Diagnostics Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Roche Diagnostics Recent Developments
11.9 Siemens Healthcare
11.9.1 Siemens Healthcare Corporation Information
11.9.2 Siemens Healthcare Overview
11.9.3 Siemens Healthcare Oncology Based Molecular Diagnostics Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Siemens Healthcare Oncology Based Molecular Diagnostics Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Siemens Healthcare Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Oncology Based Molecular Diagnostics Industry Chain Analysis
12.2 Oncology Based Molecular Diagnostics Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Oncology Based Molecular Diagnostics Production Mode & Process
12.4 Oncology Based Molecular Diagnostics Sales and Marketing
12.4.1 Oncology Based Molecular Diagnostics Sales Channels
12.4.2 Oncology Based Molecular Diagnostics Distributors
12.5 Oncology Based Molecular Diagnostics Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Oncology Based Molecular Diagnostics Industry Trends
13.2 Oncology Based Molecular Diagnostics Market Drivers
13.3 Oncology Based Molecular Diagnostics Market Challenges
13.4 Oncology Based Molecular Diagnostics Market Restraints
14 Key Findings in The Global Oncology Based Molecular Diagnostics Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer